Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Swanson

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonistJun Chiba, Nobuo Machinaga, Tohru Takashi, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2011
Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazolesPaul Ratcliffe, Lynn Abernethy, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2011
Structure-activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonistsRonald Palin, Lynn Abernethy, Nasrin Ansari, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonistJun Chiba, Nobuo Machinaga, Tohru Takashi, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2011
Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazolesPaul Ratcliffe, Lynn Abernethy, Nasrin Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2011
Structure-activity studies of a novel series of isoxazole-3-carboxamide derivatives as TRPV1 antagonistsRonald Palin, Lynn Abernethy, Nasrin Ansari, et al.
Pageof 3